ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,575Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 1107

$1.57M Total Retail Price of All Prescriptions

Rank: 18 out of 1107

686 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 686 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 686 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 13,255 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 984 490 S3 1 1
LISINOPRIL 876 535 2 2
OMEPRAZOLE 838 443 3 4
LEVOTHYROXINE SODIUM 656 464 4 3
FUROSEMIDE 634 420 5 7
SIMVASTATIN 594 408 6 5
GABAPENTIN 543 214 7 9
AMLODIPINE BESYLATE 507 397 8 6
CITALOPRAM HBR 481 151 9 17
TRAZODONE HCL 416 114 10 33
WARFARIN SODIUM 404 187 11 15
ZOLPIDEM TARTRATE 376 130 12 22
PRAVASTATIN SODIUM 353 231 13 12
NAMENDA 345 333 14 42
METFORMIN HCL 341 173 15 8
METOPROLOL TARTRATE 338 250 16 10
DONEPEZIL HCL 336 293 17 32
CRESTOR 334 178 18 23
NEXIUM 322 153 19 18
SERTRALINE HCL 297 162 20 20
POTASSIUM CHLORIDE 289 152 21 14
HYDROCHLOROTHIAZIDE 288 178 22 11
MELOXICAM 253 110 23 25
ATORVASTATIN CALCIUM 239 114 24 13
MIRTAZAPINE 232 165 25 61
LOSARTAN POTASSIUM 230 182 26 29
METOPROLOL SUCCINATE 221 155 27 16
PAROXETINE HCL 218 149 28 45
QUETIAPINE FUMARATE 217 137 29 94
RISPERIDONE 214 40 30 79
CYCLOBENZAPRINE HCL 212 47 R 31 56
BUSPIRONE HCL 205 55 32 107
CLONIDINE HCL 201 79 33 53
PANTOPRAZOLE SODIUM 197 112 34 30
PROAIR HFA 193 91 35 37
CYMBALTA 192 64 36 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 186 83 37 24
ATENOLOL 178 130 38 19
TIZANIDINE HCL 164 0 39 73
ALENDRONATE SODIUM 163 101 40 41
LANTUS 161 97 41 49
FLUTICASONE PROPIONATE 156 56 42 38
HYDROXYZINE PAMOATE 156 16 R 42 152
POLYETHYLENE GLYCOL 3350 148 67 44 46
AMITRIPTYLINE HCL 141 49 R 45 48
CLOPIDOGREL 140 81 46 28
CARVEDILOL 139 71 47 27
ABILIFY 137 79 48 170
FLUOXETINE HCL 132 46 49 47
KLOR-CON M20 131 100 50 75
BYSTOLIC 130 64 51 138
PROMETHAZINE HCL 125 42 R 52 44
LEVETIRACETAM 124 31 53 141
TRAMADOL HCL 123 62 54 26
LYRICA 122 23 55 83
PLAVIX 117 70 56 39
ISOSORBIDE MONONITRATE ER 115 76 57 34
IBUPROFEN 114 22 58 63
TAMSULOSIN HCL 113 57 59 30
ESCITALOPRAM OXALATE 111 55 60 82
SPIRIVA 110 31 61 57
INSULIN SYRINGE 110 53 61 78
ROPINIROLE HCL 106 29 63 69
OXYBUTYNIN CHLORIDE ER 106 36 63 179
TRIAMTERENE-HCTZ 104 71 65 62
ESTRADIOL 100 81 R 66 151
DIOVAN 99 72 67 51
ALLOPURINOL 99 88 67 36
TOPIRAMATE 99 13 67 160
CARBIDOPA-LEVODOPA 98 45 70 122
AZITHROMYCIN 98 49 70 35
DIVALPROEX SODIUM 96 12 72 96
RANITIDINE HCL 95 67 73 21
METHOCARBAMOL 93 31 R 74 142
DIVALPROEX SODIUM ER 92 0 75 216
VENLAFAXINE HCL 92 32 75 193
BENZTROPINE MESYLATE 88 13 R 77 174
LOVAZA 84 21 78 101
DIGOXIN 82 77 79 52
FAMOTIDINE 78 35 80 111
VENLAFAXINE HCL ER 77 61 81 117
SEROQUEL 77 46 81 182
AMOXICILLIN 76 34 83 90
MECLIZINE HCL 75 46 84 114
SUCRALFATE 74 49 85 121
JANUVIA 74 45 85 60
LIPITOR 74 32 85 109
NOVOLOG 72 52 88 127
PROPRANOLOL HCL 71 23 89 134
SPIRONOLACTONE 69 30 90 72
METHYLPREDNISOLONE 69 41 90 119
LAMOTRIGINE 68 24 92 244
LEVEMIR 67 40 93 191
RAMIPRIL 66 48 94 84
LEVOFLOXACIN 63 29 95 71
GLYBURIDE 62 31 R 96 68
ZETIA 62 41 96 76
ACETAMINOPHEN-CODEINE 61 40 S3 98 120
ZIPRASIDONE HCL 61 11 98 325
NORTRIPTYLINE HCL 60 50 100 267
ONDANSETRON HCL 60 25 100 211
OXYBUTYNIN CHLORIDE 60 16 100 171
ENALAPRIL MALEATE 59 25 103 98
DILTIAZEM 24HR CD 59 37 103 126
BACLOFEN 57 0 105 133
CIPROFLOXACIN HCL 57 37 105 59
ENABLEX 57 31 105 271
VERAPAMIL ER 57 38 105 113
EXELON 55 55 109 103
ADVAIR DISKUS 54 22 110 54
GLIPIZIDE ER 50 35 111 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.